« Previous
Next »
Journal of Clinical Virology
Volume 38, Issue 1
, Pages 7-13
, January 2007
Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing
References
- . Type distribution, viral load and integration status of high-risk human papillomavirus in pre-stages of cervical cancer (CIN). Br J Cancer. 2005;92:2195–2200
- . HPV16 and HPV 18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol. 2002;67:574–582
- . Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol. 1987;61:962–971
- . Integration of papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology. 1987;161:259–261
- . Analysis of the physical state of different human papillomavirus DNAsin intraepithelial and invasive cervical neoplasm. J Virol. 1991;65:606–612
- Persistence and load of high risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003;106:396–403
- Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev. 2002;11:3–6
- . Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA. 1987;84:1070–1074
- Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol. 2003;56:532–536
- Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol. 2004;92:873–880
- . Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. 1995;69:2989–2997
- . Disruption of E1 and E2 reading frames of HPV16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol. 1998;17:146–153
- Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999;59:6132–6136
- . Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment. Int J Gynecol Cancer. 2005;15:278–284
- Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360:228–229
- Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer. 2001;92:9–17
- . Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cancers. Virology. 1989;172:63–72
- . Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. Int J Cancer. 2004;112:854–859
- Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:517–518
- Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354:20–25
- Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol. 1997;65:121–129
- . Integrated human papilloma virus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002;40:886–891
- . Analysis of HPV16, 18, 31 and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol. 1997;50:600–604
- Prevalence of papillomavirus infection in women in Turin, Italy. Eur J Cancer. 2005;41:297–305
- . The clinical relevance of human papillomavirus testing: relationship between clinical and analytical sensitivity. J Pathol. 2003;201:1–6
- Human papillomavirus DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol. 1999;37:1030–1034
- Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene. 2003;22:1225–1237
- Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J Infect Dis. 1995;172:1184–1190
- . GP5+/6+ PCR followed by reverse line blot analysis enabled rapid and high throughput identification of human papillomavirus genotypes. J Clin Microbiol. 2002;40:779–787
- Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer. 2002;98:590–595
- . Phylogenetic classification of human papillomavirus: correlation with clinical manifestations. J Gen Virol. 1992;73:2653–2660
- . Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer. 1997;74:50–56
- The role of human papillomavirus in cyto-histological practice: distribution and prevalence of high-risk strains (16, 18, 31, 33, and 35) in intraepithelial lesions and neoplasia of the uterine cervix. Pathologica. 2000;92:516–523
- . Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 1998;48:3780–3786
- . Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences. J Virol. 1990;64:813–821
- . Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou test using real-time polymerase chain reaction analysis. Cancer. 2002;94:2199–2210
- . Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 2004;64:3784–3878
- Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancer. J Clin Microbiol. 1999;37:3514–3517
- A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene. 2003;22:3977–3984
- . Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–698
PII: S1386-6532(06)00344-1
doi: 10.1016/j.jcv.2006.09.008
© 2006 Elsevier B.V. All rights reserved.
« Previous
Next »
Journal of Clinical Virology
Volume 38, Issue 1
, Pages 7-13
, January 2007
